Carrier Screening Market Size & Growth

 The results analyzed by GME showed that the Global Carrier Screening Market will grow with a CAGR value of 17.1 percent, to hit xx billion USD by 2026. Carrier screening is a genetic test used to determine if a healthy individual is a carrier of any recessive gene or genetic disorder. It offers life-long data about the reproductive risk of a person and the likelihood of having a child with a genetic disorder. The development is expected to be driven by a rising occurrence of chromosomal anomalies and an increasing demand for carrier screening during the forecast timeline.

Browse 157 Market Data Tables and 117 Figures spread through 189 Pages and in-depth TOC on "Carrier Screening Market - Forecast to 2026" 

https://www.globalmarketestimates.com/market-report/global-carrier-screening-market-2599

By Type (Targeted Disease Carrier Screening, Expanded Carrier Screening), By Medical Condition (Neurological Conditions, Pulmonary Conditions, Hematological Conditions, Other Medical Conditions), By Technology (Microarrays, DNA Sequencing, Polymerase Chain Reaction), By End-User (Reference Laboratories, Hospitals, Physician Offices, and Clinics, Others), By Product & Service (Services, Products), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

 Key Market Insights

·         The rising incidence of chromosomal anomalies across developed and developing regions will drive the market over the forecasted timeline

·         The increasing number of accredited laboratories will help the market grow tremendously from 2021 to 2026

·         As of 2020, hospitals based on the end-user will expand the fastest with the highest value of CAGR.

·         Fulgent Genetics Inc, Sema4, Illumina Inc., Luminex Corporation, Laboratory Corporation of America Holdings, Gene By Gene, Invitae Corporation, Optogenetics Corporation, Asuragen, Pathway Genomics, Eurofins Scientific, Opko Health, Quest Diagnostics Incorporated, Myriad Genetics, Thermo Fisher Scientific Inc, Natera Inc, BGI, Progenity, Centogene, True Health are the major players competing in this market.

 

 

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-carrier-screening-market-2599

Type Outlook (Revenue, USD Billion, 2021-2026)

·        Targeted Disease Carrier Screening

·        Expanded Carrier Screening

Medical Condition Outlook (Revenue, USD Billion, 2021-2026)

·         Neurological Conditions

·         Pulmonary Conditions

·         Hematological Conditions

·         Other Medical Conditions

Technology Outlook (Revenue, USD Billion, 2021-2026)

·         Microarrays

·         DNA Sequencing

·         Polymerase Chain Reaction

Product & Service Outlook (Revenue, USD Billion, 2021-2026)

·         Services

·         Products

End-User Outlook (Revenue, USD Billion, 2021-2026)

·         Reference Laboratories

·         Hospitals, Physician Offices

·          Clinics

·         Others

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America                                                                                 

  • The U.S.
  • Canada
  • Mexico

 

 

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of APAC

Central & South America

  • Brazil
  • Argentina
  • Rest of CSA

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Rest of MEA

 

Contact: Tracy Simon

Email address: tracy.simon@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

Comments

Popular posts from this blog

Meat Starter Cultures Market Size & Growth

Pea Starch Market Size & Growth

Parking Management Market Size & Growth